Advanced search
Publication Cover
Infectious Diseases Volume 51, 2019 - Issue 9
Submit an article Journal homepage
914
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis

Wentao NiDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Jing BaoDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Donghong YangDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Wen XiDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Keqiang WangDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Yu XuDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
,
Rongbao ZhangDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaView further author information
&
Zhancheng GaoDepartment of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 639-650 | Received 07 Jul 2019, Accepted 11 Jul 2019, Published online: 29 Jul 2019

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xiaojuan Hu, Jin Xu, Pei Li & Hui Zheng. (2023) Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1949-1957.
Read now
William A Fahy, Farshid Homayoun-Valiani, Anthony Cahn, Jon Robertson, Alison Templeton, Wilhelmine H Meeraus, Robert Wilson, Mike Lowings, Miriam Marotti, Sarah L West, Maggie Tabberer & Edith M Hessel. (2021) Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1637-1646.
Read now

Articles from other publishers (19)

Louis-Marie Galerneau, Sébastien Bailly, Nicolas Terzi, Stéphane Ruckly, Maité Garrouste-Orgeas, Yves Cohen, Vivien Hong Tuan Ha, Marc Gainnier, Shidasp Siami, Claire Dupuis, Michael Darmon, Jean-Marie Forel, Guillaume Rigault, Christophe Adrie, Dany Goldgran-Toledano, Virginie Laurent, Etienne de Montmollin, Laurent Argaud, Jean Reignier, Jean-Louis Pepin & Jean-François Timsit. (2023) Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the ICU: An Observational Study From the OUTCOMEREA Database, 1997–2018. Critical Care Medicine 51:6, pages 753-764.
Crossref
Allison B Chambliss, Khushbu Patel, Jessica M Colón-Franco, Joshua Hayden, Sophie E Katz, Emi Minejima & Alison Woodworth. (2023) AACC Guidance Document on the Clinical Use of Procalcitonin. The Journal of Applied Laboratory Medicine 8:3, pages 598-634.
Crossref
G. Deniel, M. Cour, L. Argaud, J. C. Richard & L. Bitker. (2022) Early antibiotic therapy is associated with a lower probability of successful liberation from mechanical ventilation in patients with severe acute exacerbation of chronic obstructive pulmonary disease. Annals of Intensive Care 12:1.
Crossref
Pelin Uysal. 2022. Biomarkers in Medicine. Biomarkers in Medicine 425 439 .
Ada Hoffman & Michael M. Braun. (2022) Can a negative procalcitonin be used to stop antibiotics in hospitalized patients with moderate-to-severe COPD exacerbation but no signs of pneumonia?. Evidence-Based Practice 25:2, pages 30-32.
Crossref
Juan José Soler-Cataluña, Pascual Piñera, Juan Antonio Trigueros, Myriam Calle, Ciro Casanova, Borja G. Cosío, José Luis López-Campos, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea & Marc Miravitlles. (2022) [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome. Archivos de Bronconeumología 58:2, pages T159-T170.
Crossref
Juan José Soler-Cataluña, Pascual Piñera, Juan Antonio Trigueros, Myriam Calle, Ciro Casanova, Borja G. Cosío, José Luis López-Campos, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea & Marc Miravitlles. (2022) Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC. Archivos de Bronconeumología 58:2, pages 159-170.
Crossref
Mei Yang, Xuemei Liu, Qiongqiong Hu, Junjie Li, Sijia Fu, Daohong Chen, Yanqing Wu, Ai Luo, Xiawei Zhang, Ruizhi Feng, Guo Xu, Can Liu, Hongli Jiang & Wei Liu. (2022) Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study. BMJ Open 12:1, pages e051939.
Crossref
Mario Francesco Cannavò, Irene Coppolino, Francesco Monaco & Gaetano Caramori. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 631 641 .
Cédric Daubin, François Fournel, Fabrice Thiollière, Fabrice Daviaud, Michel Ramakers, Andréa Polito, Bernard Flocard, Xavier Valette, Damien Du Cheyron, Nicolas Terzi, Muriel Fartoukh, Stephane Allouche & Jean-Jacques Parienti. (2021) Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU. Annals of Intensive Care 11:1.
Crossref
Piroska Pázmány, Alexandra Soós, Péter Hegyi, Dóra Dohos, Szabolcs Kiss, Zsolt Szakács, Andrea Párniczky, András Garami, Zoltán Péterfi & Zsolt Molnár. (2021) Inflammatory Biomarkers Are Inaccurate Indicators of Bacterial Infection on Admission in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease—A Systematic Review and Diagnostic Accuracy Network Meta-Analysis. Frontiers in Medicine 8.
Crossref
Juan José Soler-Cataluña, Pascual Piñera, Juan Antonio Trigueros, Myriam Calle, Ciro Casanova, Borja G. Cosío, José Luis López-Campos, Jesús Molina, Pere Almagro, José-Tomás Gómez, Juan Antonio Riesco, Pere Simonet, David Rigau, Joan B. Soriano, Julio Ancochea & Marc Miravitlles. (2021) WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome. Archivos de Bronconeumología (English Edition).
Crossref
Mairi MacLeod, Alberto Papi, Marco Contoli, Bianca Beghé, Bartolome R. Celli, Jadwiga A. Wedzicha & Leonardo M. Fabbri. (2021) Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology 26:6, pages 532-551.
Crossref
Jiaqi Di, Xuanlin Li, Yang Xie, Shuguang Yang & Xueqing Yu. (2021) Procalcitonin‐guided antibiotic therapy in AECOPD patients: Overview of systematic reviews. The Clinical Respiratory Journal 15:6, pages 579-594.
Crossref
Wen Song, Yue Wang, Fengming Tian, Liang Ge, Xiaoqian Shang, Qiang Zeng, Ning Feng, Jiahui Fan, Jing Wang & Xiumin Ma. (2021) Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Disease Markers 2021, pages 1-9.
Crossref
Linlin Liu, Ying Luan, Ling Xiao, Ning Wang, Jing Wang & Zhaobo Cui. (2021) The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Medicine 100:16, pages e25547.
Crossref
Ken Chen, Katherine A. Pleasants, Roy A. Pleasants, Tatsiana Beiko, Ronald G. Washburn, Zhiheng Yu, Suodi Zhai & M. Bradley Drummond. (2020) Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective. Pulmonary Therapy 6:2, pages 201-214.
Crossref
Guangming Dai, Yajuan Ran, Jiajia Wang, Xingru Chen, Junnan Peng, Xinglong Li, Huojin Deng, Min Xiao & Tao Zhu. (2020) Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. Mediators of Inflammation 2020, pages 1-9.
Crossref
Jennifer Meddings, Ashwin Gupta & Nathan Houchens. (2020) Quality and safety in the literature: January 2020. BMJ Quality & Safety 29:1, pages 86-90.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.